Ambrx Biopharma Inc.
Ambrx Biopharma Inc. (AMAM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AMAM · as of Jun 9, 2026
Key Statistics
Explore Ambrx Biopharma Inc. Data
amam stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 33.3%
Competitors & Peers
amam competitorsAMAM
BIESF
BLU
DICE
EQRX
FUSNStock Performance
Full HistoryAbout Ambrx Biopharma Inc.
Ambrx Biopharma Inc. operates as a clinical-stage biotechnology company focused on the discovery and development of precisely engineered biologic medicines. The firm utilizes its unique expanded genet…
what is ambrx biopharma inc. · amam stock overview · ambrx biopharma inc. company profile · who is ambrx biopharma inc. ceo · amam NYSE · ambrx biopharma inc. headquarters · ambrx biopharma inc. business segments
About Stock Overview & Key Data
Ambrx Biopharma Inc. (AMAM) is a Healthcare company in the Biotechnology industry, listed on NYSE since Aug 14, 2023. As of the latest trading session, AMAM stock price is $28.00, with a market capitalization of $1.8B. The stock has returned +256.23% over the past 12 months and +106.79% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Ambrx Biopharma Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2022, Ambrx Biopharma Inc. reported revenue of $7.4M and net income of -$78.0M. For detailed data — including Ambrx Biopharma Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ambrx Biopharma Inc. (AMAM) stock price is $28.00. The stock is traded on NYSE under the ticker symbol AMAM. The 52-week range is $6.55 – $28.15.